Use of the aromatase inhibitor letrozole to treat male infertility

Fertility and Sterility

Volumn 92, Issue 2, 2009, Pages 829.e1-829.e2

  Patry, Geneviève ^a   Jarvi, Keith ^a   Grober, Ethan D ^a   Lo, Kirk C ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

aromatase inhibitors; Letrozole; male infertility; nonobstructive azoospermia; spermatogenesis

Indexed keywords

CLOMIFENE CITRATE; FOLLITROPIN; LETROZOLE; LUTEINIZING HORMONE; TESTOSTERONE;

ADULT; ARTICLE; AZOOSPERMIA; CASE REPORT; FOLLITROPIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MALE INFERTILITY; PRIORITY JOURNAL; SEMEN ANALYSIS; SPERMATOGENESIS; TESTIS BIOPSY; TESTOSTERONE BLOOD LEVEL; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 67651100633     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.05.014     Document Type: Article

References (5)

1. Raman J.D., and Schlegel P.N. Aromatase inhibitors for male infertility. J Urol 167 (2002) 624-629
2. Itoh N., Kumamoto Y., Maruta H., et al. Therapeutic efficacy of testolactone (aromatase inhibitor) to oligozoospermia with high estradiol/testosterone ratio. Nippon Hinyokika Gakkai Zasshi 82 (1991) 204-209
3. Schill W.B., Reiter F., Korting H.C., and Schweikert H.U. [Long-term therapy of oligozoospermia with the aromatase inhibitor testolactone]. Hautarzt 38 (1987) 395-399
4. Dony J.M., Smals A.G., Rolland R., Fauser B.C., and Thomas C.M. Effect of chronic aromatase inhibition by delta 1-testolactone on pituitary-gonadal function in oligozoospermic men. Andrologia 18 (1986) 69-78
5. Clark R.V., and Sherins R.J. Treatment of men with idiopathic oligozoospermic infertility using the aromatase inhibitor, testolactone. Results of a double-blinded, randomized, placebo-controlled trial with crossover. J Androl 10 (1989) 240-247